MICROPORT SCIENTIFIC CORPORATION Financials MicroPort Scientific Corporation
Equities
853
KYG608371046
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.9 HKD | +3.51% |
|
+11.11% | -29.93% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 1,549 | 1,915 | 9,653 | 6,537 | 4,793 | 1,381 | 1,381 | - |
| Enterprise Value (EV) 1 | 1,748 | 2,093 | 8,947 | 6,026 | 4,881 | 1,975 | 1,590 | 1,679 |
| P/E ratio | 76.8 x | 59.8 x | -49.3 x | -22 x | -10.9 x | -4.12 x | -6.22 x | -8.61 x |
| Yield | 0.38% | 0.58% | 0.1% | 0.15% | - | 0.27% | - | - |
| Capitalization / Revenue | 2.31 x | 2.41 x | 14.9 x | 8.39 x | 5.7 x | 2.08 x | 1.16 x | 1 x |
| EV / Revenue | 2.61 x | 2.64 x | 13.8 x | 7.74 x | 5.81 x | 2.08 x | 1.34 x | 1.21 x |
| EV / EBITDA | 18.3 x | 23.4 x | -92.5 x | -28.5 x | -13 x | -5.14 x | -9.05 x | -37.3 x |
| EV / FCF | 113 x | -29.7 x | -70.6 x | -12.6 x | -8.05 x | -2.66 x | -5.64 x | -6.03 x |
| FCF Yield | 0.89% | -3.37% | -1.42% | -7.95% | -12.4% | -37.6% | -17.7% | -16.6% |
| Price to Book | 3.27 x | 3.62 x | 8.59 x | 4.42 x | 4.23 x | 1.45 x | 1.6 x | 1.58 x |
| Nbr of stocks (in thousands) | 1,575,536 | 1,616,587 | 1,783,923 | 1,794,276 | 1,821,352 | 1,831,722 | 1,831,722 | - |
| Reference price 2 | 0.9834 | 1.185 | 5.411 | 3.643 | 2.631 | 0.7537 | 0.7537 | 0.7537 |
| Announcement Date | 3/27/19 | 3/30/20 | 3/30/21 | 3/30/22 | 3/30/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 669.5 | 793.5 | 648.7 | 778.6 | 840.8 | 950.7 | 1,189 | 1,387 |
| EBITDA 1 | 95.29 | 89.64 | -96.74 | -211.1 | -374.6 | -384.6 | -175.6 | -45.02 |
| EBIT 1 | 52.05 | 28.46 | -167.6 | -293.6 | -507 | -516.2 | -164.2 | -37.13 |
| Operating Margin | 7.78% | 3.59% | -25.83% | -37.71% | -60.29% | -54.29% | -13.81% | -2.68% |
| Earnings before Tax (EBT) 1 | 32.93 | 63.21 | -212.9 | -337.3 | -581.5 | -626.5 | -275.7 | -264.5 |
| Net income 1 | 23.91 | 46.28 | -191.3 | -276.5 | -436.5 | -477.6 | -210.8 | -179.6 |
| Net margin | 3.57% | 5.83% | -29.48% | -35.51% | -51.91% | -50.24% | -17.72% | -12.95% |
| EPS 2 | 0.0128 | 0.0198 | -0.1097 | -0.1654 | -0.2408 | -0.2619 | -0.1211 | -0.0875 |
| Free Cash Flow 1 | 15.54 | -70.59 | -126.7 | -479.3 | -606.6 | -588.5 | -282 | -278.7 |
| FCF margin | 2.32% | -8.9% | -19.53% | -61.55% | -72.14% | -58.81% | -23.71% | -20.1% |
| FCF Conversion (EBITDA) | 16.31% | - | - | - | - | - | - | - |
| FCF Conversion (Net income) | 64.99% | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.003700 | 0.006840 | 0.005530 | 0.005490 | - | 0.002000 | - | - |
| Announcement Date | 3/27/19 | 3/30/20 | 3/30/21 | 3/30/22 | 3/30/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2022 S1 | 2023 S1 |
|---|---|---|
| Net sales 1 | 405 | 482.6 |
| EBITDA | - | - |
| EBIT 1 | -218.6 | -164.6 |
| Operating Margin | -53.98% | -34.11% |
| Earnings before Tax (EBT) 1 | -247.8 | -206.2 |
| Net income 1 | -198.1 | -162.6 |
| Net margin | -48.92% | -33.7% |
| EPS | - | - |
| Dividend per Share | - | - |
| Announcement Date | 8/30/22 | 8/30/23 |
1USD in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | 199 | 178 | - | - | 88.6 | 186 | 209 | 299 |
| Net Cash position 1 | - | - | 706 | 511 | - | - | - | - |
| Leverage (Debt/EBITDA) | 2.089 x | 1.985 x | - | - | -0.2366 x | -0.7006 x | -1.19 x | -6.637 x |
| Free Cash Flow 1 | 15.5 | -70.6 | -127 | -479 | -607 | -589 | -282 | -279 |
| ROE (net income / shareholders' equity) | 5.66% | 9.62% | -23.2% | -21.1% | -33.2% | -32.9% | -29.7% | -17.6% |
| ROA (Net income/ Total Assets) | 2.2% | 3.22% | -9.41% | -8.07% | -10.4% | -8.19% | -4.06% | -1.67% |
| Assets 1 | 1,089 | 1,436 | 2,034 | 3,425 | 4,187 | 4,107 | 5,188 | 10,784 |
| Book Value Per Share 2 | 0.3000 | 0.3300 | 0.6300 | 0.8200 | 0.6200 | 0.5200 | 0.4700 | 0.4800 |
| Cash Flow per Share 2 | 0.0500 | 0.0200 | -0.0100 | -0.1400 | -0.1900 | -0.1600 | -0.0500 | -0.0200 |
| Capex 1 | 68.6 | 97 | 104 | 248 | 263 | 74 | 168 | 126 |
| Capex / Sales | 10.25% | 12.23% | 15.96% | 31.84% | 31.31% | 7.4% | 14.08% | 9.09% |
| Announcement Date | 3/27/19 | 3/30/20 | 3/30/21 | 3/30/22 | 3/30/23 | 3/28/24 | - | - |
1USD in Million2USD
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
0.7537
USD
Average target price
1.703
USD
Spread / Average Target
+125.96%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -29.93% | 1.38B | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- 853 Stock
- Financials MicroPort Scientific Corporation
